ESC & iPSC News Volume 16.16 | Apr 28 2021

    0
    91







    2021-04-28 | ESC 16.16


    ESC & iPSC News by STEMCELL Technologies
    Vol. 16.16 – 28 April, 2021
    TOP STORY

    Modeling Plasticity and Dysplasia of Pancreatic Ductal Organoids Derived from Human Pluripotent Stem Cells

    Researchers differentiated hPSCs into pancreatic duct-like organoids with morphological, transcriptional, proteomic, and functional characteristics of human pancreatic ducts, further maturing upon transplantation into mice.
    [Cell Stem Cell]

    AbstractGraphical Abstract

    Checking your cell quality doesn’t have to be difficult - Genetic screening with the hPSC Genetic Analysis Kit
    PUBLICATIONSRanked by the impact factor of the journal

    Principles of Signaling Pathway Modulation for Enhancing Human Naive Pluripotency Induction

    Scientists devised enhanced conditions that enabled stabilization of hPSCs with stringent naive functional and molecular properties while preserving cell-autonomous differentiation competence into embryonic, germ cell and extra-embryonic lineages.
    [Cell Stem Cell]

    Full ArticleGraphical Abstract

    Nuclear m6A Reader YTHDC1 Regulates the Scaffold Function of LINE1 RNA in Mouse ESCs and Early Embryos

    The authors report that YTHDC1 played indispensable roles in the self-renewal and differentiation potency of mouse ESCs, which highly depended on the m6A-binding ability.
    [Protein & Cell]

    Full Article

    Erosion of Human X Chromosome Inactivation Causes Major Remodeling Of the iPSC Proteome

    Investigators found that X chromosome inactivation erosion in iPSCs caused a remodeling of the proteome, affecting the expression of a much wider range of proteins and disease-linked loci than previously realized.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Design and Evaluation of an In Vitro Mild Traumatic Brain Injury Modeling System Using 3D Printed Mini Impact Device on the 3D Cultured Human iPSC Derived Neural Progenitor Cells

    Researchers report an in vitro mild traumatic brain injury modeling system based on 3D cultured human iPSC derived neural progenitor cells to evaluate consequences of single and repetitive mild traumatic brain injury using a 3D printed mini weight‐drop impact device.
    [Advanced Healthcare Materials]

    Abstract

    Efficient Generation of Osteoclasts from Human Induced Pluripotent Stem Cells and Functional Investigations of Lethal CLCN7‐Related Osteopetrosis

    Investigators report on a novel, simplified differentiation method for forming functional osteoclasts from hiPSCs.
    [Journal of Bone and Mineral Research]

    Abstract

    Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons

    Using patient-derived iPSC neurons expressing a tau aggregation biosensor, researchers developed a cell culture system that allowed continuous assessment of both induced tau aggregation and neuronal viability at single-cell resolution for periods of >1 week.
    [Journal of Neuroscience]

    Abstract

    Non-Invasive Cell Classification Using the Paint Raman Express Spectroscopy System (PRESS)

    The authors developed the Paint Raman Express Spectroscopy System, which used two fast-rotating galvano mirrors to obtain spectra from a wide area of a cell.
    [Scientific Reports]

    Full Article

    Importance of WNT-Dependent Signaling For Derivation and Maintenance of Primed Pluripotent Bovine Embryonic Stem Cells

    Scientists describe a series of experiments to determine whether derivation of ESC could be generated by replacing IWR-1 with other inhibitors of WNT signaling.
    [Biology of Reproduction]

    AbstractGraphical Abstract

    Stem Cell Conference Registration Award
    REVIEWS

    G1 – Phase Progression in Pluripotent Stem Cells

    The authors review which transcription factors and signaling pathways play a role in both maintenance of pluripotency as well as cell cycle progression.
    [Cellular and Molecular Life Sciences]

    Full Article

    INDUSTRY AND POLICY NEWS

    CARISMA Therapeutics Establishes Collaboration with Leading Cell Therapy Expert to Explore and Develop Allogeneic CAR-Macrophages

    CARISMA Therapeutics Inc. announced it has established a multi-year scientific collaboration with Bruce Blazar, MD, Regents Professor of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapy at the University of Minnesota to investigate and develop allogeneic macrophage therapies.
    [CARISMA Therapeutics (PR Newswire LLC.)]

    Press Release

    FEATURED EVENT

    ISSCR: Stem Cells and Regenerative Medicine

    January 12 – 14, 2022
    Shanghai, China

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Primate Retinal Disease

    Oregon Health & Science University – Portland, Oregon, United States

    Postdoctoral Research Fellow – Cardiac Research

    University of Michigan – Ann Arbor, Michigan, United States

    Research Associate – Disease Modeling

    Insitro – South San Francisco, California, United States

    Research Scientist – Liver

    Beam Therapeutics – Cambridge, Massachusetts, United States

    Postdoctoral Fellow Position – Neurological Diseases

    University of Alabama at Birmingham – Birmingham, Alabama, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter